Skip to content

Xencor XNCR Proceeds from the sale of future royalties

Proceeds from the sale of future royalties at other companies

Mannkind logo
MannkindMNKD
$37.5M
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$0
uniQure logo
uniQureQURE
$92.52M
Geron logo
GeronGERN
$0-100%
Perrigo Company logo
Perrigo CompanyPRGO
$1.4M-17.6%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$6.98M+122%

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept xncr:ProceedsFromFutureSaleOfRoyalties.

The official record: Xencor’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's proceeds from the sale of future royalties.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's proceeds from the sale of future royalties?
Xencor (XNCR) reported proceeds from the sale of future royalties of $0 in Q4 2025.
What does proceeds from the sale of future royalties mean?
This represents the cash proceeds received from the sale of rights to future royalty payments generated by the company's intellectual property. It is a form of non-dilutive financing used to fund operations or R&D by monetizing long-term assets upfront. Investors analyze this to understand the company's reliance on asset-based financing versus traditional equity or debt markets.